Rituximab-induced late-onset neutropenia

被引：3
|
作者：
Sahu, Kamal Kant [1 ]
Petrou, Nathan [2 ]
Cohn, Zachary [2 ]
Khanna, Shrinkhala [2 ]
机构：
[1] St Vincent Hosp, Dept Internal Med, Worcester, MA 01604 USA
[2] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA
来源：
BMJ CASE REPORTS | 2019年 / 12卷 / 12期
关键词：
infections; neurology (drugs and medicines); haematology (drugs and medicines);
D O I：
10.1136/bcr-2019-233569
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Is Rituximab-induced Late-onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders?
    Hincks, Ian
    Woodcock, Barrie E.
    Thachil, Jecko
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 411 - 413
  • [2] Clinical Characteristics of Rituximab-Induced Late Onset Neutropenia
    Yilmaz, Emrullah
    Mahani, Mohsen Ghadimi
    Bilen, Mehmet A.
    Baker, Kelty R.
    Rice, Lawrence
    BLOOD, 2011, 118 (21) : 507 - 507
  • [3] The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
    Tesfa, Daniel
    Sander, Birgitta
    Lindkvist, Henric
    Nilsson, Christer
    Kimby, Eva
    Hagglund, Hans
    Wahlin, Bjorn E.
    Klimkowska, Monika
    Palmblad, Jan
    MEDICAL ONCOLOGY, 2021, 38 (06)
  • [4] The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
    Daniel Tesfa
    Birgitta Sander
    Henric Lindkvist
    Christer Nilsson
    Eva Kimby
    Hans Hägglund
    Björn E. Wahlin
    Monika Klimkowska
    Jan Palmblad
    Medical Oncology, 2021, 38
  • [5] Late-onset neutropenia following rituximab
    McLaughlin, Peter
    LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 965 - 966
  • [6] Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab
    Athni, Tejas S.
    Barmettler, Sara
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (06) : 699 - 712
  • [7] Late-onset neutropenia following rituximab treatment for rheumatologic conditions
    Breuer, Gabriel S.
    Ehrenfeld, Michael
    Rosner, Itzhak
    Balbir-Gurman, Alexandra
    Zisman, Devy
    Oren, Shirley
    Paran, Daphna
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1337 - 1340
  • [8] Late-onset neutropenia following rituximab treatment for rheumatologic conditions
    Gabriel S. Breuer
    Michael Ehrenfeld
    Itzhak Rosner
    Alexandra Balbir-Gurman
    Devy Zisman
    Shirley Oren
    Daphna Paran
    Clinical Rheumatology, 2014, 33 : 1337 - 1340
  • [9] Rituximab and late-onset neutropenia: A French pharmacovigilance database analysis
    Trouiller, C.
    Rouby, F.
    Jonville-Bera, A. P.
    Grandvuillemin, A.
    Bagheri, H.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 95 - 96
  • [10] Rituximab-induced late-onset neutropenia (LON) after treatment of chronic lymphocytic leukemia by Fludarabine Cyclophosphamide Rituximab (FCR) regimen. A single-institution report
    Sottile, L.
    Bagheri, H.
    Ysebaert, L.
    Lapeyre-Mestre, M.
    Montastruc, J. L.
    Rigal-Huguet, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 81 - 82
12345